Evidence map›Paper›PMID 41351628›Full record

ReviewEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026

​C-arm-guided percutaneous biopsy combined with mNGS: a dual-modality strategy for op​timizing diagnosis and targeted management of spinal infections.

Shuang Liu, Pan Liu, Jiezhong Deng, Jinyue He, Yu Xiang, Hui Chen, Sheng Liao, Yanzhu Lu, Zhongrong Zhang, Jianzhong Xu and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shuang Liu *The Southwest Hospital of AMU, Chongqing, China.
Pan Liu *The Southwest Hospital of AMU, Chongqing, China.
Jiezhong DengThe Southwest Hospital of AMU, Chongqing, China.
Jinyue HeThe Southwest Hospital of AMU, Chongqing, China.
Yu XiangThe Southwest Hospital of AMU, Chongqing, China.
Hui ChenThe 958th Army Hospital of the Chinese People's Liberation Army, Chongqing, China.
Sheng LiaoThe 958th Army Hospital of the Chinese People's Liberation Army, Chongqing, China.
Yanzhu LuThe 958th Army Hospital of the Chinese People's Liberation Army, Chongqing, China.
Zhongrong ZhangThe 958th Army Hospital of the Chinese People's Liberation Army, Chongqing, China.
Jianzhong XuThe Southwest Hospital of AMU, Chongqing, China.
Zehua ZhangThe Southwest Hospital of AMU, Chongqing, China. zhangzehua@tmmu.edu.cn.

Funding

Chongqing Science and Health Joint Medical Research(CN) 2025ZDXM002
6 · The paper itself

Abstract

backgroundSpinal infections pose diagnostic dilemmas owing to nonspecific early symptoms (e.g., back pain and fever) overlapping with degenerative, neoplastic, or inflammatory conditions, resulting in high misdiagnosis rates. Metagenomic next-generation sequencing (mNGS) offers rapid culture-independent pathogen detection, and its clinical utility in spinal infections when integrated with C-arm-guided percutaneous biopsy remains inadequately characterized.

objectiveTo evaluate the diagnostic value of integrating C-arm-guided percutaneous biopsy with mNGS and conventional microbial culture for spinal infections.

methodsA retrospective, single-center study was conducted on 34 suspected cases of spinal infections. Specimens obtained via C-arm-guided percutaneous biopsy were subjected to mNGS, microbial culture, and clinical correlation analysis to establish a definitive diagnosis. The diagnostic performance metrics of mNGS and microbial culture were compared.

resultsmNGS demonstrated a significantly higher overall detection rate (91.18%) than microbial culture (55.88%) (p < 0.001). Subgroup analysis based on needle trajectories (parapedicular vs. transpedicular approaches) revealed no statistically significant difference in pathogen detection rates between the two methods (p > 0.05), indicating that the needle trajectory did not affect diagnostic outcomes. Both approaches achieved comparable efficacies under C-arm guidance.

conclusionmNGS combined with C-arm-guided percutaneous biopsy significantly improves pathogen detection rates over traditional cultures, offering high diagnostic accuracy for complex spinal infections regardless of the biopsy approach. The clinical integration of imaging and laboratory data is essential for optimizing interpretation and avoiding diagnostic pitfalls. While mNGS costs approximately 4500 RMB per test versus 150 RMB for culture at our institution, early targeted therapy reduced the average hospitalization by 4–6 days, yielding net cost savings of 2000 RMB per case based on local hospitalization fees (1300 RMB/day).

Indexed as

High-Throughput Nucleotide SequencingImage-Guided BiopsySpinal DiseasesAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesC-arm-guided percutaneous biopsyDiagnostic efficacyMetagenomic Next-Generation sequencing (mNGS)Microbial cultureSpinal infection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.